ES534494A0 - Un procedimiento para preparar un derivado de mono-sialo-gangliosido - Google Patents

Un procedimiento para preparar un derivado de mono-sialo-gangliosido

Info

Publication number
ES534494A0
ES534494A0 ES534494A ES534494A ES534494A0 ES 534494 A0 ES534494 A0 ES 534494A0 ES 534494 A ES534494 A ES 534494A ES 534494 A ES534494 A ES 534494A ES 534494 A0 ES534494 A0 ES 534494A0
Authority
ES
Spain
Prior art keywords
ganglioside
mono
sialo
sub
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES534494A
Other languages
English (en)
Other versions
ES8603191A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of ES8603191A1 publication Critical patent/ES8603191A1/es
Publication of ES534494A0 publication Critical patent/ES534494A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ES534494A 1983-07-21 1984-07-20 Un procedimiento para preparar un derivado de mono-sialo-gangliosido Granted ES534494A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48724/83A IT1168205B (it) 1983-07-21 1983-07-21 Derivato di monsialo ganglioside dotato di attivita' antibatterica, antifungina ed antitumorale, composizioni che lo contengono e procedimento per la loro preparazione

Publications (2)

Publication Number Publication Date
ES8603191A1 ES8603191A1 (es) 1985-12-01
ES534494A0 true ES534494A0 (es) 1985-12-01

Family

ID=11268264

Family Applications (1)

Application Number Title Priority Date Filing Date
ES534494A Granted ES534494A0 (es) 1983-07-21 1984-07-20 Un procedimiento para preparar un derivado de mono-sialo-gangliosido

Country Status (9)

Country Link
US (2) US4728641A (es)
EP (1) EP0136438B1 (es)
JP (1) JPS6084296A (es)
AT (1) ATE75480T1 (es)
DE (1) DE3485680D1 (es)
DK (1) DK166828B1 (es)
ES (1) ES534494A0 (es)
HU (1) HU198091B (es)
IT (1) IT1168205B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH660557A5 (fr) * 1984-10-26 1987-05-15 Nestle Sa Composition anti-bacterienne et procede de preparation de ses constituants actifs.
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
JPH0653764B2 (ja) * 1985-07-31 1994-07-20 三井東圧化学株式会社 モノシアロガングリオシドの製造法
ATE94395T1 (de) * 1986-05-09 1993-10-15 Pulverer Gerhard Verwendung von spezifischen monosacchariden zur herstellung eines arzneimittels zur verhinderung von metastasen maligner tumore.
IT1208751B (it) * 1986-06-30 1989-07-10 Fidia Farmaceutici Possibile uso dei gangliosidi esogeni in malattie tumorali come fattore protettivo contro la neurotossicita' da farmaci antitumorali
EP0255717A3 (en) * 1986-08-06 1990-12-05 Mect Corporation Ganglioside related compounds and method of producing the same
IT1212041B (it) * 1987-11-02 1989-11-08 Fidia Farmaceutici Gangliosidi esteri interni come agenti terapeutici capaci di eliminare il dolore nelle neuropatie periferiche
AU6902691A (en) * 1989-12-13 1991-07-18 Glycomed Incorporated Synthetic receptor molecules recognizable by a rotavirus
AU7153991A (en) * 1989-12-13 1991-07-18 Glycomed Incorporated Synthesis of rotavirus receptor saccharides
WO1993002686A1 (en) * 1991-07-31 1993-02-18 The Regents Of The University Of California Gangliosides with immunosuppressive ceramide moieties
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
DE4204907A1 (de) * 1992-02-14 1993-08-19 Reutter Werner Neuartige glykokonjugate mit n-substituierten neuraminsaeuren als mittel zur stimulierung des immunsystems
TW261533B (es) * 1992-07-16 1995-11-01 Kirin Brewery
KR100281264B1 (ko) * 1992-10-22 2001-02-01 마나배 게이사꾸 신규한 스핀고당 지질 및 그의 사용
JP4020958B2 (ja) * 1993-04-15 2007-12-12 キリンファーマ株式会社 新規スフィンゴ糖脂質およびその使用
DE19602108A1 (de) * 1996-01-22 1997-07-24 Beiersdorf Ag Gegen Bakterien, Parasiten, Protozoen, Mycota und Viren wirksame Substanzen
US5747476A (en) 1996-07-17 1998-05-05 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoal myeloencephalitis
DE19643585A1 (de) * 1996-10-22 1998-04-23 Beiersdorf Ag Antiadhäsive Sphingolipide
WO2002018401A2 (en) * 2000-09-01 2002-03-07 Neuronyx, Inc. Novel synthetic gangliosides
AU2001288671A1 (en) * 2000-09-01 2002-03-13 Neuronyx, Inc. Novel synthetic gangliosides
US9969980B2 (en) * 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
EP1358910A1 (de) * 2002-05-02 2003-11-05 B.R.A.H.M.S Aktiengesellschaft Verfahren und Mittel zur Prävention, Hemmung und Therapie von Krebserkrankungen
EP1367395A1 (de) * 2002-05-02 2003-12-03 B.R.A.H.M.S Aktiengesellschaft Diagnose von Neoplasmen mit Hilfe von anti-Gangliosid-Antikörpern
US9969977B2 (en) * 2002-09-20 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
WO2004080960A2 (en) 2003-03-06 2004-09-23 Neose Technologies Inc. Methods and compositions for the enzymatic synthesis of gangliosides
JP4965063B2 (ja) * 2004-05-07 2012-07-04 雪印メグミルク株式会社 口腔内細菌叢改善剤、抗菌剤及び生育促進剤。
NZ554324A (en) 2004-09-23 2012-03-30 Csr Building Products Ltd Hybrid ventilator which can be driven either by a motor or by wind
US8354370B2 (en) * 2007-06-15 2013-01-15 Garnet Biotherapeutics, Inc. Administering a biological composition or compositions isolated from self-renewing colony forming somatic cell growth medium to treat diseases and disorders
WO2009123877A1 (en) * 2008-03-21 2009-10-08 Braincells, Inc. A method of treating a nervous system disorder by modulation of neurogenesis with mcc-257
DE102010024041A1 (de) * 2010-05-16 2013-04-04 Alfred Kroll Symtomfreiheit der Atemwege

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT295036B (de) * 1968-11-29 1971-12-27 Leikola Erkki E Verfahren zur Herstellung von neuen Produkten tierischen Ursprungs
US4125492A (en) * 1974-05-31 1978-11-14 Pedro Cuatrecasas Affinity chromatography of vibrio cholerae enterotoxin-ganglioside polysaccharide and the biological effects of ganglioside-containing soluble polymers
FR2478104B1 (fr) * 1980-03-17 1986-08-08 Merieux Inst Nouveaux derives de gangliosides, leur preparation et leur application
EP0058665B1 (en) * 1980-05-09 1986-02-26 LEFFLER, Hakon Carbohydrate derivatives for inhibiting bacterial adherence
CH658458A5 (fr) * 1981-12-17 1986-11-14 Lucchini Lab Sa Procede pour l'obtention du lacto-n-norhexaosyl ceramide.

Also Published As

Publication number Publication date
EP0136438B1 (en) 1992-04-29
HUT35690A (en) 1985-07-29
ES8603191A1 (es) 1985-12-01
IT1168205B (it) 1987-05-20
EP0136438A3 (en) 1987-05-13
DK356984A (da) 1985-01-22
JPS6084296A (ja) 1985-05-13
HU198091B (en) 1989-07-28
US4831021A (en) 1989-05-16
ATE75480T1 (de) 1992-05-15
IT8348724A1 (it) 1985-01-21
DE3485680D1 (de) 1992-06-04
EP0136438A2 (en) 1985-04-10
DK356984D0 (da) 1984-07-20
IT8348724A0 (it) 1983-07-21
US4728641A (en) 1988-03-01
DK166828B1 (da) 1993-07-19

Similar Documents

Publication Publication Date Title
DE3485680D1 (de) Gangliosid-derivate.
AU549885B2 (en) Heparin degradation via ascorbic acid, cupric acetate and hydrogen peroxide
EP0140544A3 (en) Method for preparation of graft polymer membranes, and anion and cation exchange membranes
ES2003863A4 (es) Procedimiento para producir una preparacion de liberacion controlada de metoprolol y uso de dicha preparacion.
IT1148790B (it) Soluzioni medicinali stabili, applicabili per via parenterale dotate di azione anti-infiammatoria
ES2033871T3 (es) Un procedimiento para producir una preparacion de insulina para administracion parenteral.
ATE27914T1 (de) Verwendung von n-acetyl(alpha, beta) aspartylglutaminsaeure zur herstellung eines arzneimittels mit anti-allergischer wirkung zur lokalen verabreichung.
AU6076886A (en) Novel pharmaceutical compositions intended to the treatment of neuropathies and insuring the nervous regeneration
ES341109A1 (es) Metodo para la preparacion de nuevas sales basicas de adi- cion de acido ribonucleico.
BR8700656A (pt) Processo para tratar madeira,para torna-la menos suscetivel a deterioracao por fungos e bacterias,e produto
ES2004218A6 (es) Procedimiento para preparar derivados de purina
ES8107299A1 (es) Un procedimiento para la preparacion de un producto de cul- tivo o un liquido de cultivo de la nueva cepa trichosporon kashiwayama
Watanabe Sinanomycin (Netropsin) Produced By Streptomyces Sp. No. 7618 Studies on the Antibiotic Substances From Actinomyces, XXXVII
ES8503950A1 (es) Un metodo de produccion de una preparacion de plasma activada con zymosan
ES8506749A1 (es) Procedimiento para la produccion de 1-n -(l-3-amino-2-hidroxipropionilo)- o 1-n-(l-4-amino-2-hidroxibutirilo)-2',3'-dideoxikanamicina a
CN110882263A (zh) 礁膜寡二糖与礁膜寡二糖衍生物在抗乳腺癌中的应用
FI50125C (fi) Menetelmä terapeuttisesti käytettävien /1,1-ditienyyli-1-hydroksi-prop yyli-(3)/-/1-fenyyli-alkyyli/-amiinien ja näiden suolojen valmistamise ksi.
IT8020100A0 (it) Medicamento, o preparato farmaceutico, ad azione citostatica.
DE2835878A1 (de) Oligosaccharid mit durch glucocorticoide bedingte enzyminduktion verstaerkender wirkung, verfahren zu seiner herstellung und diese verbindung enthaltende arzneimittel
CA995248A (en) Process for the preparation of 4-chloro-2,5-dimethoxy-aniline
GB1409503A (en) Process for preparing amino-anthraquinones
FI46262C (fi) Mikrobiologinen menetelmä (-)(cis-1,2-epoksipropyyli)fosfonihapon valm istamiseksi.
ES469749A1 (es) Un procedimiento para la preparacion de una formulacion far-maceutica de una droga de notroimidazol.
Finkelstein Thromboplastic Activity of Placenta Extract
MD515C2 (ro) Procedeu de prelucrare a seminţelor înainte de semănat

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519